GlassScriptPhysician profile
Mir I Ali
NPI 1568490670
$8,894.21
in general payments reported to CMS, 2019-2025
49 companies · $1,066 in 2025
The $1,066 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,331 · 2020: $927 · 2021: $258 · 2022: $383 · 2023: $520 · 2024: $1,409 · 2025: $1,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,994.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $3,015.10 | 2019-2020 | |
| Livanova USA, INC. | $837.56 | 2020-2021 | |
| Boston Scientific Corporation | $498.55 | 2019-2025 | Avvigo Guidance System, General - Therapies |
| Novartis Pharmaceuticals Corporation | $418.58 | 2019-2025 | |
| Endologix LLC | $368.38 | 2024 | Endocross Device, Torus Stent Graft System |
| Janssen Pharmaceuticals, INC | $256.64 | 2019-2024 | Xarelto |
| Heartflow, INC. | $251.74 | 2022-2025 | Ffrct |
| Inari Medical, INC. | $249.80 | 2019-2022 | |
| Abiomed | $231.45 | 2022-2024 | |
| Penumbra, INC. | $218.42 | 2019-2025 | Penumbra System, Indigo System |
| Stryker Corporation | $211.75 | 2025 | Flowtriever, Intri24 Introducer Sheath |
| Astrazeneca Pharmaceuticals LP | $208.74 | 2019-2025 | Brilinta, Farxiga, Wainua |
| Pfizer INC. | $199.80 | 2019-2025 | |
| Philips North America LLC | $185.67 | 2019-2025 | (6571) Eagle Eye, Eagle Eye, Angiosculpt Cv Rx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $146.19 | 2024-2025 | Lifevest |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mir Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.